imiquimod has been researched along with Weight Loss in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Hu, Y; Liu, H; Tang, CC; Xiang, TN; Ye, XL; Zheng, YJ | 1 |
Cooper, KD; Fu, PF; Griffith, AD; McCormick, TS; Popkin, DL; Soler, DC; Young, AE | 1 |
Dalrymple, J; Hanger, C; Hepburn, D | 1 |
3 other study(ies) available for imiquimod and Weight Loss
Article | Year |
---|---|
[Reduning Injection protects flu-infected mice by inhibiting infiltration of inflammatory cells in lung and down-regulating cytokine storm].
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Chemokine CCL5; Chemokine CXCL10; Cytokine Release Syndrome; Cytokines; Drugs, Chinese Herbal; Female; Imiquimod; Interleukin-10; Interleukin-6; Lung; Mice; Mice, Inbred C57BL; Oseltamivir; Phosphates; RNA; RNA, Messenger; Tumor Necrosis Factor-alpha; Weight Loss | 2022 |
Overexpression of AQP3 and AQP10 in the skin exacerbates psoriasiform acanthosis.
Topics: Aminoquinolines; Animals; Aquaporin 3; Aquaporins; Cell Differentiation; Dermatitis; Detergents; Epidermis; Filaggrin Proteins; Imiquimod; Intermediate Filament Proteins; Keratin-10; Keratinocytes; Membrane Proteins; Mice; Up-Regulation; Weight Loss | 2017 |
Systemic side effects from topical imiquimod.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Blood Sedimentation; Carcinoma, Basal Cell; Depression; Facial Neoplasms; Fatigue; Feeding and Eating Disorders; Humans; Hypotension, Orthostatic; Imiquimod; Male; Treatment Outcome; Weight Loss | 2005 |